MediPharm Labs【LABS】銘柄情報

MediPharm Labs Corp (LABS) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

0.07

( - )

買値

0.07

売値

0.075

出来高

12,139

0.07 日の範囲 0.07

0.06 52 週間の範囲 0.10

時価総額

29.74M

前日終値

0.07

始値

0.07

時刻

5000

0.07

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

$ 296,748

発行済株式数

424,864,269

配当利回り

PER

-3.37

1 株当たり利益 (EPS)

-0.02

歳入

43.28M

純利益

-8.75M

MediPharm Labs Corp. operates as a pharmaceutical company that produces and sells purified, pharmaceutical-like cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, processes, ... MediPharm Labs Corp. operates as a pharmaceutical company that produces and sells purified, pharmaceutical-like cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products. It also provides good manufacturing practice flower sourcing, packaging, and distribution services, as well as dried flower, pre-roll, and other cannabis products. In addition, the company offers cannabis related medical information and services; and cannabis clinic services for patients requiring medical cannabis education and prescriptions. MediPharm Labs Corp. was founded in 2015 and is based in Barrie, Canada. 詳細を表示

セクター

Healthcare

業界

Pharmaceuticals

ウェブサイト

www.medipharmlabs.com

本社

Barrie, Canada

設立

2026

MediPharm Labs Corp is listed in the Healthcare sector of the トロント証券取引所 with ticker LABS. The last closing price for MediPharm Labs was $0.07. Over the last year, MediPharm Labs shares have traded in a share price range of $ 0.06 to $ 0.10.

MediPharm Labs currently has 424,864,269 shares in issue. The market capitalisation of MediPharm Labs is $29.74 million. MediPharm Labs has a price to earnings ratio (PE ratio) of -3.37.

MediPharm Labs Announces Voting Results from the 2026 Annual and Special Meeting of Shareholders

TORONTO, June 17, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ...

MediPharm Labs Reminds Shareholders of Upcoming Annual and Special Meeting

Annual and Special Meeting to be held virtually on Wednesday, June 17, 2026 at 11:00 a.m. (Eastern Time).The...

MediPharm Labs Reports First Quarter 2026 Results Achieving Positive Adjusted EBITDA

Q1 2026 Positive Adjusted EBITDA(1)Net Revenue of $9M with strong gross margins of 37%OPEX decreased 28% in Q1...

MediPharm Labs Sets Date to Report First Quarter 2026 Financial Results

TORONTO, May 07, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ...

MediPharm Labs Positioned to Serve Growing U.S. Pharmaceutical and Clinical Research Demand Following Cannabis Rescheduling

On April 22, 2026, the U.S. Department of Justice and Drug Enforcement Administration’s final order...

MediPharm Labs Reports Full Year & Fourth Quarter 2025 Results with Over 40% Annual Growth in International Medical Revenue

FY 2025 revenue of $45.1 million, an increase of 8% over 2024International Medical Cannabis revenue increased...

Historic U.S. Cannabis Rescheduling Unlocks Potential Growth Opportunities for MediPharm Labs, Backed by the Company's Suite of Licenses and Proven U.S. Clinical Trial Supply Experience

TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.005	-6.66666666667	0.075	0.075	0.07	75282	0.07035603	CS
4	-0.01	-12.5	0.08	0.08	0.07	154281	0.07256649	CS
12	0.01	16.6666666667	0.06	0.1	0.06	306483	0.07877535	CS
26	-0.005	-6.66666666667	0.075	0.1	0.06	232315	0.07510813	CS
52	-0.005	-6.66666666667	0.075	0.1	0.06	269113	0.07365	CS
156	0.01	16.6666666667	0.06	0.12	0.055	254472	0.0747769	CS
260	-0.41	-85.4166666667	0.48	0.49	0.055	315601	0.12161346	CS